EndoBarrier®: a Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes?
Open Access
- 15 February 2018
- journal article
- research article
- Published by Springer Nature in Obesity Surgery
- Vol. 28 (7) , 1980-1989
Abstract
Background and Aims Obesity associated with diabetes mellitus is a significant worldwide problem associated with considerable health care costs. Whilst surgical intervention is effective, it is invasive, costly and associated with complications. This study aims to evaluate the safety and efficacy of the EndoBarrier®, a duodenal-jejunal sleeve bypass as an alternative treatment of diabetes mellitus in obese patients. Materials and Methods This was a multi-centre, non-randomised trial recruiting obese patients with type 2 diabetes from three sites in the UK. Eligible participants had a BMI of 30–50 kg/m2 and HbA1c levels of 7.5–10%. The study comprised a 12-month period with the EndoBarrier® inserted and a 6-month follow-up period after it had been explanted. The primary study outcomes were weight, BMI, HbA1c levels and fasting insulin and glucose levels. Results Forty-five patients were recruited and 31 patients (69%) completed the 12-month study period. Significant reductions in weight (95%CI 0.62–29.38; p < 0.05) and BMI (95%CI 1.1–8.7; p < 0.005) were documented 12 months after device insertion. The mean HbA1c was significantly reduced (95%CI 0.1–1.6; p < 0.05) after the device insertion period and reductions in metabolic parameters (fasting insulin and glucose levels) were also documented during the study. Adverse events were also assessed in all patients, the vast majority of which were reported as mild. Conclusions The EndoBarrier® appears to be a safe and effective treatment strategy in overweight patients with poor glycaemic control despite medical therapy, or in those who are eligible but decline bariatric surgery.Keywords
Funding Information
- Imperial College London
This publication has 22 references indexed in Scilit:
- Gastric bypass reduces fat intake and preferenceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- A Multicenter, Randomized Efficacy Study of the EndoBarrier Gastrointestinal Liner for Presurgical Weight Loss Prior to Bariatric SurgeryAnnals of Surgery, 2010
- Perioperative Safety in the Longitudinal Assessment of Bariatric SurgeryNew England Journal of Medicine, 2009
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Is Glycemic Control Improving in U.S. Adults?Diabetes Care, 2008
- Increasing Cardiovascular Disease Burden Due to Diabetes MellitusCirculation, 2007
- Body Composition, Dietary Intake, and Energy Expenditure After Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Vertical Banded GastroplastyAnnals of Surgery, 2006
- Surgical Options for ObesityGastroenterology Clinics of North America, 2005
- Diabetes and Hypertension in Severe Obesity and Effects of Gastric Bypass-Induced Weight LossAnnals of Surgery, 2003
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998